Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Adamas Pharmaceuticals, Inc.

NASDAQ: ADMSHealthcare / Drugs - Generic / USA
9.42-0.56-5.61%Vol 130 7161Y Perf -74.17%
Dec 10th, 2018 11:59
BID9.40 ASK9.43
Open9.95 Previous Close9.98
Pre-Market- After-Trading-
 - -%  - -%
Target Price
36.00 
Analyst Rating
Strong Buy 1.50
Potencial %
284.21 
Finscreener Ranking
★★★ —    -
Insiders Trans % 3/6/12M
-/-50/-83 
Value Ranking
 —    -
Insiders Value % 3/6/12M
22/-42/-84 
Growth Ranking
★★     46.21
Insiders Shares Cnt. % 3/6/12M
40/-15/-71 
Income Ranking
 —    -
Market Cap (mil)258 
Earnings Rating
Price Range Ratio 52wk %
1.12 
Earnings Date
1st Nov 2018

Today's Price Range

9.2610.06

 

52wk Range

9.0344.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-23.23%
3 Months
-56.29%
6 Months
-64.15%
1 Year
-74.17%
3 Years
-37.39%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ADMS9.42-0.5600-5.61
AAPL165.14-3.3500-1.99
GOOG1 033.74-2.8400-0.27
MSFT104.69-0.1300-0.12
XOM75.10-2.5400-3.27
WFC48.52-1.7400-3.46
JNJ143.08-2.3500-1.62
FB140.212.79002.03
GE6.81-0.2000-2.85
JPM99.99-3.3000-3.19
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
8.60
Current Ratio
8.90
Long Term Debt to Total Capital
0.50
Total Debt to Equity
1.01
Interest Coverage
-6.60
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
99.00
EBIT Margin
-542.70
EBITDA Margin
-536.10
Pre-tax Profit Margin
-5 873.80
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
2.45
PS Ratios
13.14
Price to Cash Flow
23.20
Price to Free Cash Flow
-2.60
Cash Flow Per Share
-4.09
Price to Tangible Book
2.45
Book Value per Share
4.18
Enterprise Value (in ths.)
183 802
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-31.75
ROE last 12 Months
-131.87
Return on Assets (5Y Avg)
-15.96
ROA last 12 Months
-66.94
Return on Capital (5Y Avg)
-1.24
ROC last 12 Months
-66.72
Return on invested Capital Q
-11.89
Return on invested Capital Y
-42.74
Assets Turnover
0.10
Receivables Turnover
6.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
21 299
Revenue per Share
0.78
Revenue Growth 3 Years
18.52
Revenue Growth 5 Years
-51.06
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-1.34-1.228.96
Q02 2018-1.41-1.2610.64
Q01 2018-1.38-1.352.17
Q04 2017-1.15-1.27-10.43
Q03 2017-1.03-1.04-0.97
Q02 2017-0.85-0.93-9.41
Q01 2017-0.72-0.720.00
Q04 2016-0.82-0.6817.07
Earnings Per EndEstimateRevision %Trend
12/2018 QR-1.39-0.72Negative
12/2018 FY-5.232.61Positive
3/2019 QR-1.204.76Positive
12/2019 FY-3.87-2.93Negative
Next Report Date-
Estimated EPS Next Report-1.34
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume130 716
Shares Outstanding (in ths.)27 340
Trades Count461
Dollar Volume1 056 821
Avg. Volume734 324
Avg. Weekly Volume539 926
Avg. Monthly Volume524 862
Avg. Quarterly Volume649 147

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

68%32%

Bearish Bullish

49%51%

Bearish Bullish

53%47%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (75.00 %)
6 (75.00 %)
9 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (25.00 %)
2 (25.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.00

There are no comments yet.

News